About this FactMed analysis covering adverse side effect reports of AGGRENOX patients who developed HYPERCHOLESTEROLAEMIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 17 individuals taking AGGRENOX reported HYPERCHOLESTEROLAEMIA to the FDA. A total of 3940 AGGRENOX drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between AGGRENOX and HYPERCHOLESTEROLAEMIA. In doing so, we compare AGGRENOX with other drugs that cause HYPERCHOLESTEROLAEMIA, to help you evaluate whether or not AGGRENOX causes HYPERCHOLESTEROLAEMIA. Likewise, this page shows the most highly-reported side effects of AGGRENOX, so you can see if HYPERCHOLESTEROLAEMIA ranks among AGGRENOX's most well-known side effects.
Summary Statistics
Reports of AGGRENOX causing HYPERCHOLESTEROLAEMIA: 17
Reports of any side effect of AGGRENOX : 3940
Percentage of AGGRENOX patients where HYPERCHOLESTEROLAEMIA is a reported side effect: 0.4315%

FDA reports of any drug causing HYPERCHOLESTEROLAEMIA : 5656
Average percentage for all medicated patients where HYPERCHOLESTEROLAEMIA is reported as a complication: 0.0354%

Physician opinion on AGGRENOX as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing AGGRENOX:
CEREBROVASCULAR ACCIDENT PROPHYLAXIS ( 573 patients )
TRANSIENT ISCHAEMIC ATTACK ( 426 patients )
CEREBROVASCULAR ACCIDENT ( 325 patients )
PROPHYLAXIS ( 114 patients )
DRUG USE FOR UNKNOWN INDICATION ( 81 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 80 patients )
ANTICOAGULANT THERAPY ( 71 patients )
THROMBOSIS PROPHYLAXIS ( 25 patients )
ANTIPLATELET THERAPY ( 24 patients )
ISCHAEMIC STROKE ( 14 patients )
CAROTID ARTERY OCCLUSION ( 14 patients )
HYPERTENSION ( 12 patients )
ISCHAEMIC CEREBRAL INFARCTION ( 11 patients )
ATRIAL FIBRILLATION ( 11 patients )
CORONARY ARTERY DISEASE ( 9 patients )
CEREBRAL INFARCTION ( 7 patients )
VASCULAR SHUNT ( 7 patients )
THROMBOSIS ( 7 patients )
ARTERIAL DISORDER ( 7 patients )
LACUNAR INFARCTION ( 6 patients )
CARDIAC DISORDER ( 5 patients )
PLATELET AGGREGATION ABNORMAL ( 5 patients )
ANGIOPATHY ( 5 patients )
ISCHAEMIC HEART DISEASE PROPHYLAXIS ( 5 patients )
CEREBRAL ISCHAEMIA ( 5 patients )
CEREBROVASCULAR DISORDER ( 4 patients )
CARDIOVASCULAR DISORDER ( 4 patients )
CEREBROVASCULAR INSUFFICIENCY ( 4 patients )
CARDIOVASCULAR EVENT PROPHYLAXIS ( 4 patients )
HYPERHOMOCYSTEINAEMIA ( 3 patients )
CAROTID ARTERY STENOSIS ( 3 patients )
HYPOAESTHESIA FACIAL ( 3 patients )
REVERSIBLE ISCHAEMIC NEUROLOGICAL DEFICIT ( 3 patients )
EPILEPSY ( 3 patients )
COAGULOPATHY ( 3 patients )
HEMIPARESIS ( 3 patients )
DIZZINESS ( 3 patients )
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE ( 2 patients )
PHLEBITIS SUPERFICIAL ( 2 patients )
VARICOSE VEIN ( 2 patients )
CAROTID ARTERY DISEASE ( 2 patients )
MIGRAINE ( 2 patients )
CEREBRAL HAEMORRHAGE ( 2 patients )
BLOOD PRESSURE ( 2 patients )
SPEECH DISORDER ( 2 patients )
PAIN ( 2 patients )
CEREBRAL THROMBOSIS ( 2 patients )
PERIPHERAL ISCHAEMIA ( 2 patients )
ARTERY DISSECTION ( 2 patients )
VASCULAR CALCIFICATION ( 2 patients )
CONVULSION ( 2 patients )
POST PROCEDURAL STROKE ( 2 patients )
ANGINA PECTORIS ( 2 patients )
CEREBELLAR INFARCTION ( 2 patients )
HYPOAESTHESIA ( 2 patients )
BLOOD DISORDER ( 2 patients )
HYPOPERFUSION ( 2 patients )
OPTIC NERVE INFARCTION ( 2 patients )
ILL-DEFINED DISORDER ( 2 patients )
ENZYME ABNORMALITY ( 2 patients )
ESSENTIAL THROMBOCYTHAEMIA ( 1 patients )
THYROID STIMULATING IMMUNOGLOBULIN ( 1 patients )
ARTERIAL STENOSIS ( 1 patients )
FEELING ABNORMAL ( 1 patients )
ARTHRITIS ( 1 patients )
CEREBROVASCULAR STENOSIS ( 1 patients )
HAEMODILUTION ( 1 patients )
MEMORY IMPAIRMENT ( 1 patients )
VASCULAR DEMENTIA ( 1 patients )
ATRIAL FLUTTER ( 1 patients )
CONCUSSION ( 1 patients )
PLATELET COUNT ( 1 patients )
AMNESIA ( 1 patients )
VASCULITIS ( 1 patients )
BALANCE DISORDER ( 1 patients )
CEREBRAL ARTERIOSCLEROSIS ( 1 patients )
DIALYSIS ( 1 patients )
MUSCULAR WEAKNESS ( 1 patients )
VERTIGO ( 1 patients )
BASAL GANGLION DEGENERATION ( 1 patients )
OFF LABEL USE ( 1 patients )
HYPOTENSION ( 1 patients )
AORTIC VALVE REPLACEMENT ( 1 patients )
EMBOLIC STROKE ( 1 patients )
BRAIN STEM INFARCTION ( 1 patients )
INFARCTION ( 1 patients )
THROMBOEMBOLIC STROKE ( 1 patients )
ARRHYTHMIA ( 1 patients )
PAROXYSMAL NOCTURNAL HAEMOGLOBINURIA ( 1 patients )
BRAIN STEM SYNDROME ( 1 patients )
ISCHAEMIA ( 1 patients )
ARTERIAL OCCLUSIVE DISEASE ( 1 patients )
EYE DISORDER ( 1 patients )
CARDIOMYOPATHY ( 1 patients )
GASTROOESOPHAGEAL REFLUX DISEASE ( 1 patients )
PLASMA VISCOSITY DECREASED ( 1 patients )
PLATELET AGGREGATION INHIBITION ( 1 patients )
AMAUROSIS FUGAX ( 1 patients )
MICROANGIOPATHY ( 1 patients )
ATRIAL SEPTAL DEFECT REPAIR ( 1 patients )
HYPERLIPIDAEMIA ( 1 patients )
MIXED CONNECTIVE TISSUE DISEASE ( 1 patients )
VASCULITIS CEREBRAL ( 1 patients )
BASAL GANGLIA INFARCTION ( 1 patients )
DEEP VEIN THROMBOSIS ( 1 patients )
CEREBRAL ATHEROSCLEROSIS ( 1 patients )
NERVOUS SYSTEM DISORDER ( 1 patients )
VISUAL IMPAIRMENT ( 1 patients )
RUPTURED CEREBRAL ANEURYSM ( 1 patients )
ANXIETY ( 1 patients )
CEREBRAL HYPOPERFUSION ( 1 patients )
DYSARTHRIA ( 1 patients )
BLOOD PRESSURE ABNORMAL ( 1 patients )
STENT PLACEMENT ( 1 patients )
APHASIA ( 1 patients )
PARAESTHESIA ( 1 patients )
BRAIN STEM ISCHAEMIA ( 1 patients )
INFLAMMATION ( 1 patients )
( 0 patients )
Drugs with high FDA adverse event association with HYPERCHOLESTEROLAEMIA:

FOSAMAX (4571 patients)
VIOXX (2808 patients)
SEROQUEL (1156 patients)
ASPIRIN (1059 patients)
ZOMETA (631 patients)
LIPITOR (552 patients)
ALENDRONATE SODIUM (513 patients)
FOSAMAX PLUS D (502 patients)
AREDIA (484 patients)
ZOCOR (466 patients)
LASIX (387 patients)
ZYPREXA (363 patients)
PRILOSEC (353 patients)
NEXIUM (351 patients)
SYNTHROID (346 patients)
CALCIUM (UNSPECIFIED) (344 patients)
XANAX (338 patients)
PREDNISONE (333 patients)
CELEBREX (326 patients)
NEURONTIN (312 patients)
LISINOPRIL (312 patients)
COUMADIN (293 patients)
SIMVASTATIN (281 patients)
AMBIEN (277 patients)
PAXIL (277 patients)
PLAVIX (276 patients)
VITAMINS (UNSPECIFIED) (271 patients)
HYDROCHLOROTHIAZIDE (267 patients)
PREVACID (256 patients)
ATIVAN (255 patients)
ZOLOFT (250 patients)
CRESTOR (249 patients)
OMEPRAZOLE (230 patients)
TOPROL-XL (230 patients)
PROTONIX (223 patients)
VICODIN (221 patients)
NORVASC (220 patients)
MULTI-VITAMINS (215 patients)
ATENOLOL (214 patients)
TAMOXIFEN CITRATE (214 patients)
[THERAPY UNSPECIFIED] (208 patients)
ACETAMINOPHEN (207 patients)
RISPERDAL (205 patients)
PREMARIN (203 patients)
PROZAC (200 patients)
DIGOXIN (200 patients)
ALBUTEROL (199 patients)
FOLIC ACID (196 patients)
BONIVA (195 patients)
OXYCONTIN (194 patients)
LEVAQUIN (194 patients)
PREDNISOLONE (192 patients)
ZANTAC (189 patients)
ARIMIDEX (187 patients)
VITAMIN D (UNSPECIFIED) (183 patients)
AMOXICILLIN (182 patients)
GLUCOPHAGE (180 patients)
VITAMIN E (169 patients)
FUROSEMIDE (169 patients)
PERCOCET (168 patients)
ALLEGRA (168 patients)
HEPARIN SODIUM INJECTION (167 patients)
POTASSIUM CHLORIDE (165 patients)
FEMARA (163 patients)
VITAMIN D (161 patients)
ZESTRIL (160 patients)
OXYCODONE HCL (160 patients)
CALCIUM CARBONATE (160 patients)
ALLOPURINOL (160 patients)
TYLENOL (CAPLET) (159 patients)
DECADRON (159 patients)
DEXAMETHASONE (159 patients)
METHOTREXATE (158 patients)
IBUPROFEN (158 patients)
AVANDIA (158 patients)
ACTONEL (154 patients)
LORTAB (152 patients)
NITROGLYCERIN (151 patients)
LORAZEPAM (145 patients)
CELEXA (141 patients)
PRAVACHOL (140 patients)
ALPRAZOLAM (139 patients)
CALCIUM (138 patients)
GABAPENTIN (138 patients)
MORPHINE (136 patients)
DIOVAN (136 patients)
ACTEMRA (135 patients)
LOPRESSOR (134 patients)
TYLENOL (133 patients)
LEVOTHYROXINE SODIUM (133 patients)
CYCLOSPORINE (132 patients)
TRAZODONE HCL (132 patients)
LEXAPRO (131 patients)
ARANESP (130 patients)
WELLBUTRIN (127 patients)
CEPHALEXIN (124 patients)
CHEMOTHERAPEUTICS NOS (123 patients)
REGLAN (123 patients)
ADVAIR DISKUS 100/50 (120 patients)
CLONAZEPAM (120 patients)
WARFARIN SODIUM (118 patients)
INSULIN (117 patients)
TAXOL (117 patients)
ZYRTEC (116 patients)
TOCILIZUMAB (115 patients)
ALTACE (115 patients)
METFORMIN HCL (114 patients)
ZITHROMAX (113 patients)
COMPAZINE (112 patients)
REMICADE (111 patients)
EFFEXOR (110 patients)
CLINDAMYCIN (109 patients)
METOPROLOL (109 patients)
COREG (109 patients)
ULTRAM (109 patients)
LANTUS (108 patients)
ZETIA (107 patients)
CLOZARIL (107 patients)
ASCORBIC ACID (106 patients)
KEFLEX (106 patients)
CYTOXAN (105 patients)
THALIDOMIDE (102 patients)
HORMONES (UNSPECIFIED) (102 patients)
HYDROCODONE BITARTRATE (101 patients)
CYMBALTA (100 patients)
CLONIDINE (100 patients)
TAXOTERE (99 patients)
COZAAR (98 patients)
PEPCID (98 patients)
REVLIMID (97 patients)
ZOFRAN (96 patients)
KLONOPIN (96 patients)
DEPAKOTE (95 patients)
LYRICA (95 patients)
XELODA (94 patients)
GLUCOSAMINE (93 patients)
PREDNISONE TAB (92 patients)
MYCOPHENOLATE MOFETIL (91 patients)
GEMFIBROZIL (90 patients)
MOBIC (90 patients)
FLONASE (90 patients)
COLACE (89 patients)
PRAVASTATIN (89 patients)
DYAZIDE (89 patients)
RADIATION THERAPY (88 patients)
CALCIUM (UNSPECIFIED) AND VITAMIN D (UNSPECIFIED) (88 patients)
RESTORIL (86 patients)
TYLENOL-500 (85 patients)
HYDROCODONE (85 patients)
SINGULAIR (84 patients)
HERCEPTIN (84 patients)
FASLODEX (84 patients)
ADRIAMYCIN PFS (83 patients)
CLARITIN (83 patients)
METOPROLOL TARTRATE (83 patients)
ELAVIL (82 patients)
VANCOMYCIN (82 patients)
FERROUS SULFATE TAB (80 patients)
LUPRON (80 patients)
AMLODIPINE (80 patients)
FISH OIL (80 patients)
FLEXERIL (79 patients)
DIAZEPAM (78 patients)
ACCUPRIL (78 patients)
DARVOCET-N 100 (78 patients)
PREMPRO (78 patients)
PRINIVIL (77 patients)
DURAGESIC-100 (77 patients)
METHYLPREDNISOLONE (76 patients)
SOMA (76 patients)
AVONEX (76 patients)
OXYCODONE (76 patients)
AUGMENTIN '125' (76 patients)
VALIUM (76 patients)
ACIPHEX (75 patients)
ADVIL (75 patients)
FLOMAX (74 patients)
ACYCLOVIR (74 patients)
TENORMIN (74 patients)
ACTOS (73 patients)
RANITIDINE (73 patients)
EVISTA (73 patients)
IMDUR (71 patients)
SKELAXIN (71 patients)
LOVENOX (71 patients)
CORTICOSTEROIDS (UNSPECIFIED) (71 patients)
METRONIDAZOLE (71 patients)
SPIRIVA (69 patients)
TRICOR (69 patients)
BACTRIM (69 patients)
CARDIZEM (68 patients)
BUSPAR (68 patients)
KLOR-CON (68 patients)
HEPARIN (68 patients)
PROVERA (67 patients)
DARVOCET-N 50 (67 patients)
VITAMIN B-12 (65 patients)
CERTICAN (65 patients)
BEXTRA (65 patients)
MORPHINE SULFATE (64 patients)
NAPROSYN (64 patients)
RISPERIDONE (64 patients)
ATROVENT (64 patients)
VIAGRA (64 patients)
AZITHROMYCIN (64 patients)
LIDOCAINE (64 patients)
CIPROFLOXACIN (63 patients)
MAGNESIUM (62 patients)
TRAZODONE HYDROCHLORIDE (62 patients)
NEUPOGEN (62 patients)
Most common side effects for patients taking AGGRENOX:
HEADACHE (532 patients)
CEREBROVASCULAR ACCIDENT (466 patients)
NAUSEA (408 patients)
DIZZINESS (303 patients)
TRANSIENT ISCHAEMIC ATTACK (267 patients)
VOMITING (254 patients)
ASTHENIA (240 patients)
DIARRHOEA (234 patients)
FATIGUE (182 patients)
PAIN (176 patients)
FALL (170 patients)
PAIN IN EXTREMITY (149 patients)
DYSPNOEA (144 patients)
ANAEMIA (134 patients)
CHEST PAIN (130 patients)
RENAL FAILURE ACUTE (124 patients)
OEDEMA PERIPHERAL (122 patients)
ANXIETY (121 patients)
DEPRESSION (118 patients)
ABDOMINAL PAIN UPPER (113 patients)
HYPOAESTHESIA (112 patients)
HYPERTENSION (110 patients)
HYPOTENSION (105 patients)
MALAISE (104 patients)
CONFUSIONAL STATE (103 patients)
URINARY TRACT INFECTION (99 patients)
RENAL FAILURE (98 patients)
BACK PAIN (98 patients)
PNEUMONIA (96 patients)
WEIGHT DECREASED (95 patients)
ARTHRALGIA (94 patients)
GAIT DISTURBANCE (94 patients)
MYOCARDIAL INFARCTION (89 patients)
PYREXIA (89 patients)
DEHYDRATION (85 patients)
DRUG INEFFECTIVE (83 patients)
COUGH (83 patients)
MYALGIA (79 patients)
ATRIAL FIBRILLATION (79 patients)
CONVULSION (77 patients)
MUSCULAR WEAKNESS (77 patients)
DYSPHAGIA (76 patients)
LOSS OF CONSCIOUSNESS (76 patients)
PRURITUS (73 patients)
SOMNOLENCE (72 patients)
CONSTIPATION (72 patients)
CEREBRAL HAEMORRHAGE (72 patients)
FEELING ABNORMAL (72 patients)
INSOMNIA (71 patients)
ABDOMINAL PAIN (68 patients)
GASTROINTESTINAL HAEMORRHAGE (68 patients)
DECREASED APPETITE (67 patients)
RASH (67 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (66 patients)
HAEMORRHAGE (65 patients)
BLOOD PRESSURE INCREASED (65 patients)
DEATH (62 patients)
DYSPEPSIA (60 patients)
INJURY (59 patients)
BLOOD GLUCOSE INCREASED (59 patients)
SYNCOPE (59 patients)
ABDOMINAL DISCOMFORT (58 patients)
CEREBRAL INFARCTION (57 patients)
VISION BLURRED (57 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (57 patients)
HEMIPARESIS (56 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (56 patients)
RESPIRATORY FAILURE (55 patients)
MUSCLE SPASMS (54 patients)
CONTUSION (54 patients)
MEMORY IMPAIRMENT (54 patients)
NEUROPATHY PERIPHERAL (54 patients)
CARDIAC DISORDER (54 patients)
FLUSHING (53 patients)
HAEMOGLOBIN DECREASED (53 patients)
GASTRITIS (53 patients)
PARAESTHESIA (53 patients)
PALPITATIONS (52 patients)
SINUSITIS (50 patients)
RENAL FAILURE CHRONIC (50 patients)
DYSARTHRIA (50 patients)
EPISTAXIS (49 patients)
HYPERHIDROSIS (48 patients)
CARDIAC FAILURE CONGESTIVE (48 patients)
THROMBOCYTOPENIA (46 patients)
TREMOR (45 patients)
DYSGEUSIA (44 patients)
BALANCE DISORDER (44 patients)
CATARACT (43 patients)
SEPSIS (43 patients)
APHASIA (42 patients)
CORONARY ARTERY DISEASE (41 patients)
DEMENTIA (41 patients)
ABDOMINAL DISTENSION (40 patients)
SPEECH DISORDER (40 patients)
CONDITION AGGRAVATED (40 patients)
DIABETES MELLITUS (40 patients)
OFF LABEL USE (40 patients)
RETCHING (39 patients)
NECK PAIN (39 patients)
BLOOD PRESSURE DECREASED (39 patients)
WEIGHT INCREASED (38 patients)
BLOOD CHOLESTEROL INCREASED (38 patients)
ARTERIOSCLEROSIS (38 patients)
OSTEONECROSIS OF JAW (38 patients)
ATELECTASIS (38 patients)
EMOTIONAL DISTRESS (37 patients)
DIVERTICULUM (37 patients)
DYSPNOEA EXERTIONAL (37 patients)
DUODENAL ULCER (37 patients)
RECTAL HAEMORRHAGE (36 patients)
OSTEOPENIA (36 patients)
DEEP VEIN THROMBOSIS (36 patients)
RIB FRACTURE (36 patients)
CHEST DISCOMFORT (36 patients)
ANHEDONIA (35 patients)
URINARY INCONTINENCE (35 patients)
ABASIA (33 patients)
BLOOD CREATININE INCREASED (33 patients)
HYPERSENSITIVITY (33 patients)
ACUTE MYOCARDIAL INFARCTION (32 patients)
LUNG NEOPLASM MALIGNANT (32 patients)
VERTIGO (32 patients)
CARDIAC ARREST (32 patients)
HYPERLIPIDAEMIA (32 patients)
ERYTHEMA (31 patients)
MENTAL STATUS CHANGES (31 patients)
ISCHAEMIC STROKE (31 patients)
COLONIC POLYP (31 patients)
CAROTID ARTERY STENOSIS (31 patients)
TOOTHACHE (31 patients)
MUSCULOSKELETAL STIFFNESS (31 patients)
OVERDOSE (31 patients)
DYSPHONIA (31 patients)
TOOTH DISORDER (30 patients)
BLINDNESS (30 patients)
NIGHT SWEATS (30 patients)
AGEUSIA (29 patients)
LETHARGY (29 patients)
NEPHROGENIC SYSTEMIC FIBROSIS (29 patients)
INFECTION (29 patients)
HAEMORRHOIDS (29 patients)
BRONCHITIS (29 patients)
URINARY RETENTION (29 patients)
DRY MOUTH (28 patients)
HAEMATURIA (28 patients)
HERPES ZOSTER (28 patients)
CYST (28 patients)
HYPOGLYCAEMIA (28 patients)
HALLUCINATION (28 patients)
HEAD INJURY (28 patients)
NEPHROLITHIASIS (28 patients)
RENAL CYST (28 patients)
EMPHYSEMA (27 patients)
HAEMATOMA (27 patients)
DISORIENTATION (27 patients)
THROMBOSIS (27 patients)
AMNESIA (27 patients)
FOOT FRACTURE (27 patients)
ANOREXIA (27 patients)
PLATELET COUNT DECREASED (27 patients)
INTERVERTEBRAL DISC DEGENERATION (27 patients)
GASTRITIS EROSIVE (27 patients)
CHILLS (27 patients)
ROTATOR CUFF SYNDROME (26 patients)
UPPER GASTROINTESTINAL HAEMORRHAGE (26 patients)
WHEEZING (26 patients)
HIP FRACTURE (26 patients)
DRUG INTERACTION (26 patients)
VISUAL IMPAIRMENT (26 patients)
FAECAL INCONTINENCE (25 patients)
SUBDURAL HAEMATOMA (25 patients)
CARDIOMEGALY (25 patients)
INCORRECT DOSE ADMINISTERED (25 patients)
CARDIO-RESPIRATORY ARREST (25 patients)
ORTHOSTATIC HYPOTENSION (25 patients)
CAROTID ARTERY OCCLUSION (25 patients)
BONE PAIN (25 patients)
MITRAL VALVE INCOMPETENCE (25 patients)
OSTEOARTHRITIS (25 patients)
HYPOKALAEMIA (25 patients)
HOT FLUSH (24 patients)
IRRITABLE BOWEL SYNDROME (24 patients)
PULMONARY FIBROSIS (24 patients)
SKIN TIGHTNESS (24 patients)
NOCTURIA (24 patients)
HYPERKALAEMIA (24 patients)
UNRESPONSIVE TO STIMULI (24 patients)
PLEURAL EFFUSION (24 patients)
OSTEOPOROSIS (24 patients)
HEART RATE INCREASED (24 patients)
JOINT SWELLING (24 patients)
TINNITUS (24 patients)
INFLUENZA LIKE ILLNESS (24 patients)
MIGRAINE (24 patients)
METABOLIC ACIDOSIS (23 patients)
RASH GENERALISED (23 patients)
ALANINE AMINOTRANSFERASE INCREASED (23 patients)
ALOPECIA (23 patients)
TACHYCARDIA (23 patients)
OESOPHAGITIS (23 patients)
INFLUENZA (23 patients)
HAEMATEMESIS (23 patients)
SPINAL OSTEOARTHRITIS (23 patients)
HYPERCALCAEMIA (23 patients)
COMA (23 patients)
CEREBRAL ATROPHY (23 patients)
SINUS BRADYCARDIA (23 patients)
AGITATION (22 patients)
TIBIA FRACTURE (22 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for AGGRENOX


Issue Description / Topic Timestamp
QUESTION
NEUROPATHY
I am a 76 yr old female and take Aggrenox. Lately I have noticed numbness on the soles of both feet and above one knee to buttock and am trying to determine the cause. My doctor is guessing two pinched spinal nerves and has sent me to physical therapist. I've not noticed a change thus far and am trying to do my own sleuthing. Has anyone else had this reaction to the drug? 2014-11-21 20:22:34
QUESTION
MACULAR DEGENERATION
I've being taking aggrenox for a few years and although i'd recently was diagnosed with macular distrophy, i did not think aggrenox as a probable cause but on the other hand the Dr that diagnosed me told me that since there was no family history nor other facts like look at an eclipse directly etc he found no cause at so early age im 47, my question is, could be my problem a correlated cause of using this medicine, aggrenox? 2014-11-24 19:06:28
QUESTION
MACROGLOSSIA
I began taking Aggrenox Jan 2014. In approx June 2015 I was diagnosed with macroglossia - tongue swelling. Any chance it is caused by Aggrenox? I have been tested for allergies that was negative. Tongue is pushing on front teeth in sleep moving upper jaw significantly. Help! 2015-12-04 17:51:00
QUESTION
BURNING SENSATION
headackes and burning sensation over most of body. Can this be caused by taking Aggrenox? 2016-02-08 19:59:22
QUESTION
DRY MOUTH
Can aggrenox cause dry mouth? 2016-07-31 20:15:08

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about HYPERCHOLESTEROLAEMIA and AGGRENOX, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking AGGRENOX, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in AGGRENOX. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for AGGRENOX experts. If you are a healthcare provider experienced in prescribing AGGRENOX, please register here.

Your online appointment book for Carney Rentals & Services

© 2014 FactMed, Inc
Privacy Policy
Terms of Use